Skip to main content

Algert Global LLC

SEC CIK
0001275218
Latest filing
Aug 13, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
12
Since Q3 2021
Holdings of FATE by Algert Global LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−106,920−100.0%Sold outHolders
Q3 2025106,920$134.7K<0.1%+106,920NewHolders
Q1 20250$00.0%−65,510−100.0%Sold outHolders
Q4 202465,510$108.1K<0.1%−101−0.2%ReducedHolders
Q3 202465,611$229.6K<0.1%00.0%UnchangedHolders
Q2 202465,611$215.2K<0.1%+49,931+318.4%AddedHolders
Q1 202415,680$115.1K<0.1%−64,974−80.6%ReducedHolders
Q4 202380,654$301.6K<0.1%−11,210−12.2%ReducedHolders
Q3 202391,864$194.8K<0.1%−444,967−82.9%ReducedHolders
Q2 2023536,831$2.56M0.1%+156,294+41.1%AddedHolders
Q1 2023380,537$2.17M0.1%+380,537NewHolders
Q2 20220$00.0%−21,356−100.0%Sold outHolders
Q1 202221,356$828.0K0.1%+12,245+134.4%AddedHolders
Q4 20219,111$533.0K0.1%+1,190+15.0%AddedHolders
Q3 20217,921$469.0K0.1%+7,921NewHolders